Article ID: 26-0183
Injectable three-drug anesthesia in mice combines an α2-adrenoceptor agonist, a benzodiazepine and an opioid, as in the medetomidine–midazolam–butorphanol mixture and its newer variant, dexmedetomidine–remimazolam–butorphanol. Atipamezole, the usual reversal agent, antagonizes only the α2-adrenoceptor agonist, but does not directly reverse benzodiazepine-mediated activity. We examined whether adding the benzodiazepine antagonist flumazenil to atipamezole hastens emergence and alters post-anesthetic body temperature. Male C57BL/6JJcl mice received one of the two mixtures intraperitoneally and, 40 min later, atipamezole alone or with flumazenil (0.5 mg/kg each) in a 2 × 2 factorial design (n=6 per group). Flumazenil shortened the interval from antagonist administration to return of the righting reflex (RORR) by 4.54 min (95% CI, 1.93–7.15; P=0.002), with no anesthetic × antagonist interaction (P=0.62), although the study was not powered to establish equivalent effects between mixtures. Flumazenil approximately halved the temperature decline before RORR (P<0.001) without a detectable change in cooling rate (P=0.18), a pattern consistent with less time spent cooling rather than improved thermoregulation. Active warming was discontinued at antagonist administration in all groups, so the additional benefit under continued warming remains unknown. Later in recovery, temperature differences reflected the anesthetic mixture rather than the antagonist, dexmedetomidine–remimazolam–butorphanol-treated mice being 1.73°C warmer at the interpolated 220-min point (P=0.003). Adjunctive flumazenil hastened emergence under the tested conditions but does not replace thermal support and monitoring during recovery.